103 related articles for article (PubMed ID: 11389178)
41. Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure.
Vaziri ND; Zhou XJ; Naqvi F; Smith J; Oveisi F; Wang ZQ; Purdy RE
Am J Physiol; 1996 Jul; 271(1 Pt 1):E113-22. PubMed ID: 8760088
[TBL] [Abstract][Full Text] [Related]
42. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule.
Roczniak A; Burns KD
Am J Physiol; 1996 Jan; 270(1 Pt 2):F106-15. PubMed ID: 8769828
[TBL] [Abstract][Full Text] [Related]
43. Redox modulation of Gi protein expression and adenylyl cyclase signaling: role of nitric oxide.
Anand-Srivastava MB; Di Fusco F
Antioxid Redox Signal; 2004 Apr; 6(2):385-92. PubMed ID: 15025940
[TBL] [Abstract][Full Text] [Related]
44. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
45. Nitric oxide reduces bacterial superantigen-immune cell activation and consequent epithelial abnormalities.
Rachlis A; Watson JL; Lu J; McKay DM
J Leukoc Biol; 2002 Aug; 72(2):339-46. PubMed ID: 12149425
[TBL] [Abstract][Full Text] [Related]
46. Characterization of galanin and 5-HT1A receptor coupling to adenylyl cyclase in discrete regions of the rat brain.
Billecocq A; Hedlund PB; Bolaños-Jiménez F; Fillion G
Eur J Pharmacol; 1994 Oct; 269(2):209-17. PubMed ID: 7531647
[TBL] [Abstract][Full Text] [Related]
47. Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum.
Crawford CA; McDougall SA; Meier TL; Collins RL; Watson JB
Psychopharmacology (Berl); 1998 Mar; 136(1):34-43. PubMed ID: 9537680
[TBL] [Abstract][Full Text] [Related]
48. Induction of hippocampal LTD requires nitric-oxide-stimulated PKG activity and Ca2+ release from cyclic ADP-ribose-sensitive stores.
Reyes-Harde M; Potter BV; Galione A; Stanton PK
J Neurophysiol; 1999 Sep; 82(3):1569-76. PubMed ID: 10482770
[TBL] [Abstract][Full Text] [Related]
49. Adenylyl cyclase types I and VI but not II and V are selectively inhibited by nitric oxide.
Goldstein J; Silberstein C; Ibarra C
Braz J Med Biol Res; 2002 Feb; 35(2):145-51. PubMed ID: 11847517
[TBL] [Abstract][Full Text] [Related]
50. Effect of gold compounds on the activity of adenylyl cyclase in human lymphocyte membranes.
Lazarevic MB; Yan K; Swedler WI; Rasenick MM; Skosey JL
Arthritis Rheum; 1992 Aug; 35(8):857-64. PubMed ID: 1642653
[TBL] [Abstract][Full Text] [Related]
51. Forskolin increases phosphorylated-CREB and fos immunoreactivity in rat striatum.
Simpson JN; McGinty JF
Neuroreport; 1994 Jun; 5(10):1213-6. PubMed ID: 7919167
[TBL] [Abstract][Full Text] [Related]
52. Differences in type II, IV, V and VI adenylyl cyclase isoform expression between rat preadipocytes and adipocytes.
Serazin-Leroy V; Morot M; de Mazancourt P; Giudicelli Y
Biochim Biophys Acta; 2001 Nov; 1550(1):37-51. PubMed ID: 11738086
[TBL] [Abstract][Full Text] [Related]
53. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
Ng SS; Pang CC
Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
[TBL] [Abstract][Full Text] [Related]
54. Nitric oxide inhibits potassium transport in the rat distal colon.
Aizman R; Brismar H; Celsi G
Am J Physiol; 1999 Jan; 276(1):G146-54. PubMed ID: 9886990
[TBL] [Abstract][Full Text] [Related]
55. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus.
Petrenko S; Olianas MC; Onali P; Gessa GL
Eur J Pharmacol; 1987 Apr; 136(3):425-8. PubMed ID: 3609127
[TBL] [Abstract][Full Text] [Related]
56. Post-receptor-mediated increases in adenylate cyclase activity after chronic antidepressant treatment: relationship to receptor desensitization.
Newman ME; Lerer B
Eur J Pharmacol; 1989 Mar; 162(2):345-52. PubMed ID: 2721569
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of the catalytic activity of alcohol dehydrogenase by nitric oxide is associated with S nitrosylation and the release of zinc.
Gergel D; Cederbaum AI
Biochemistry; 1996 Dec; 35(50):16186-94. PubMed ID: 8973191
[TBL] [Abstract][Full Text] [Related]
58. Activation of opioid and muscarinic receptors stimulates basal adenylyl cyclase but inhibits Ca2+/calmodulin- and forskolin-stimulated enzyme activities in rat olfactory bulb.
Olianas MC; Onali P
J Neurochem; 1994 Jul; 63(1):161-8. PubMed ID: 8207425
[TBL] [Abstract][Full Text] [Related]
59. Regulation of neurotransmitter reuptake by nitric oxide.
Pögün S; Kuhar MJ
Ann N Y Acad Sci; 1994 Nov; 738():305-15. PubMed ID: 7832440
[No Abstract] [Full Text] [Related]
60. PK 11195 blockade of benzodiazepine-induced inhibition of forskolin-stimulated adenylate cyclase activity in the striatum.
Tenn CC; Neu JM; Niles LP
Br J Pharmacol; 1996 Sep; 119(2):223-8. PubMed ID: 8886401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
